Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04458311 |
| Title | Abiraterone Acetate in Combination With Tildrakizumab (ACTIon) |
| Acronym | ACTIon |
| Recruitment | Terminated |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Institute of Cancer Research, United Kingdom |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Bellinzona Hospital | Bellinzona | Switzerland | Details | |||
| Cancer Research Centre at Weston Park Hospital | Sheffield | England | S1O 2SJ | United Kingdom | Details | |
| Belfast City Hospital | Belfast | UK | United Kingdom | Details | ||
| The Royal Marsden Hospital Foundation Trust | Sutton | UK | United Kingdom | Details | ||
| Addenbrooke's Hospital | Cambridge | United Kingdom | Details | |||
| University Hospitals Southampton NHS Foundation Trust | Southampton | United Kingdom | Details |